Buscar (Noticias)

SLNO 4-DAY DEADLINE ALERT: Hagens Berman Alerts Soleno Therapeutics (SLNO) Investors To Securities Class Action Alleging Hyperphagia Drug Launch Disruptions Hagens Berman

english top health

(MENAFN - GlobeNewsWire - Nasdaq) SAN FRANCISCO, May 01, 2026 (GLOBE NEWSWIRE) -- National shareholder rights law firm Hagens Berman reminds investors in Soleno Therapeutics, Inc. (NASDAQ: SLNO) of ...
2026-05-01 12:31:44